3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
33
Lung Neoplasms
13
Breast Neoplasms
12
Colorectal Neoplasms
11
Ovarian Neoplasms
10
Recurrence
9
Neoplasms
9
Small Cell Lung Carcinoma
8
Neoplasm Metastasis
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Lymphoma, Large B-Cell, Diffuse
7
Prostatic Neoplasms
6
Carcinoma, Hepatocellular
6
Triple Negative Breast Neoplasms
5
Pancreatic Neoplasms
5
Diabetes Mellitus, Insulin-Dependent, 12
5
Carcinoma
5
Multiple Myeloma
4
Lymphoma, Follicular
4
Cholangiocarcinoma
4
Uterine Cervical Neoplasms
3
Recurrent Squamous Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Mesothelioma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Kidney Neoplasms
3
Interventions
Irinotecan
4
Gemcitabine
4
130-nm albumin-bound paclitaxel
4
Albumin-Bound Paclitaxel
3
pembrolizumab
2
napabucasin
2
Ascorbic Acid
2
trifluridine tipiracil drug combination
1
pralsetinib
1
alectinib
1
Paclitaxel
1
Nivolumab
1
Leucovorin
1
KRN-330
1
Imatinib Mesylate
1
HhAntag691
1
Fluorouracil
1
Cyclophosphamide
1
Cisplatin
1
Capecitabine
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Digestive System Diseases
×
durvalumab
×
Clear all
No trials found.